The Lancet  Neurology Autoimmune Disorder Conference

The Lancet Neurology Autoimmune Disorders Conference

March 26-27, 2015 | Barcelona, Spain

PODCAST
Listen to a conference preview from Conference Chairs, Elena Becker-Barros, Josep Dalmau and Francesc Graus.



Download file (10MB)

Speakers

Lisa Boulanger, Princeton University, USA
Susannah Cahalan, Author, Brain on Fire, USA
Graham Collingridge
, Centre for Synaptic Plasticity, University of Bristol, UK
Yanick Crow, Paris Descartes University, France, and University of Manchester, UK
Josep Dalmau, University of Pennsylvania, USA and University of Barcelona, IDIBAPS, and ICREA, Spain
Francesc Graus, University of Barcelona and IDIBAPS, Spain
Laurent Groc, Interdisciplinary Institute for Neuroscience, Bordeaux, France
Daniel Javitt, Columbia University College of Physicians and Surgeons, USA
Melike Lakadamyali, Advanced Fluorescence Imaging and Biophysics Group, ICFO, Spain
Vanda Lennon, Mayo Clinic College of Medicine, Rochester, MN, USA
Stuart Lipton, Sanford-Burnham Medical Research Institute, The Scripps Research Institute, and University of California, San Diego, USA
Rafael Maldonado, Pompeu Fabra University, Spain
Isabel Perez-Otano, University of Navarra Medical School, Spain
Richard Ransohoff, Cleveland Clinic Foundation, Lerner Research Institute, USA
Kevin Rostasy, Medical University of Innsbruck, Austria
David Sulzer, Columbia University Medical Center, New York, USA
Maarten Titulaer, Erasmus Medical Center, Rotterdam, The Netherlands
Harmut Wekerle, Max Planck Institute of Neurobiology, Germany



The first case series of patients with anti-NMDA receptor encephalitis, an autoimmune disorder of the brain, were reported in 2007. The NMDA receptor has a crucial role in synaptic function, and this novel disease is not only providing insights into the function of the receptor in humans, but also into understanding immunological mechanisms of brain disease.

With this event, The Lancet Neurology will have the opportunity to disseminate cutting-edge clinical and laboratory findings, and to facilitate an authoritative discussion of autoimmune targets in the CNS, such as the NMDA receptor, paving the way for future research into immunological and synaptic mechanisms of brain disease.

The event will have a translational focus, covering mechanisms of immunity in the CNS, clinical consequences of autoimmunity, and experimental models to study anti-NMDA receptor encephalitis and other neurological diseases.

We look forward to seeing you in Barcelona.


Elena Becker-Barroso, Editor, The Lancet Neurology


Josep Dalmau, University of Pennsylvania, USA and University of Barcelona, IDIBAPS, and ICREA, Spain

Francesc Graus
, University of Barcelona and IDIBAPS, Spain

 

 

 

 

Organised by

The Lancet

Supporting Journal

The Lancet Neurology

Sponsored by

The Lancet Neurology

The Lancet Neurology

Hashtag